Feedback
Settings

Settings

Goto Application

1. WO2006116399 - USE OF NOVEL COMPOUNDS FOR IBD TREATMENT

PermaLink
Publication Number WO/2006/116399
Publication Date 02.11.2006
International Application No. PCT/US2006/015624
International Filing Date 26.04.2006
IPC
A61K 31/17 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
17having the group N-C(O)-N or N-C(S)-N, e.g. urea, thiourea, carmustine
CPC
A61K 31/17
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
16Amides, e.g. hydroxamic acids
17having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
A61P 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
A61P 1/04
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
1Drugs for disorders of the alimentary tract or the digestive system
04for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applicants
  • FERRING B.V. [NL]/[NL] (AllExceptUS)
  • RIVIERE, Pierre, J-M. [FR]/[US] (UsOnly)
  • CHANG, Chia-Ping [US]/[US] (UsOnly)
  • DESREUMAUX, Pierre [FR]/[FR] (UsOnly)
Inventors
  • RIVIERE, Pierre, J-M.
  • CHANG, Chia-Ping
  • DESREUMAUX, Pierre
Agents
  • BENT, Stephen, A.
Priority Data
60/675,97228.04.2005US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) USE OF NOVEL COMPOUNDS FOR IBD TREATMENT
(FR) UTILISATION DE NOUVEAUX COMPOSES DANS LE TRAITEMENT DES MALADIES INFLAMMATOIRES INTESTINALES
front page image
Abstract
(EN)
The present invention relates to use of novel compounds for the manufacture of a medicament for treatment of inflammatory bowel disease (IBD) as well as to a method for treatment of IBD, wherein said compounds are administered. The compounds are represented by the general formula (I) , as further defined in the specification.
(FR)
L'invention concerne l'utilisation de nouveaux composés dans la fabrication d'un médicament servant à traiter les maladies inflammatoires intestinales (IBD), ainsi qu'une méthode de traitement de ces maladies, consistant à administrer les composés selon l'invention. Lesdits composés sont représentés par la formule générale (I), telle que définie dans la description.
Also published as
EP1874283
US20100261796
CA2602368
JP2008539246
Latest bibliographic data on file with the International Bureau
# -